Wednesday, May 11, 2022 1:31:04 PM
It’s been a while since I’ve posted here. I’m not a person who knows Dr Bala, but I thought I’d chime in as someone who treats this disease (I have 3 on treatment right now).
I’m a radiation oncologist (MD MPH) and I was blown away by the results. Even though the study design was not perfect, with this kind of disease I cannot imagine it not getting approval due to its low toxicity and potential benefit.
I shared the results with other colleagues (including one an MD PhD) and the response was “wow! I wonder when this will be available to us!”
Any product that can give even a few months of survival is huge in glioblastoma. When word gets out to other physicians they will be asking for this.
I’m a radiation oncologist (MD MPH) and I was blown away by the results. Even though the study design was not perfect, with this kind of disease I cannot imagine it not getting approval due to its low toxicity and potential benefit.
I shared the results with other colleagues (including one an MD PhD) and the response was “wow! I wonder when this will be available to us!”
Any product that can give even a few months of survival is huge in glioblastoma. When word gets out to other physicians they will be asking for this.
Recent NWBO News
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
